Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study

被引:157
|
作者
Silini, E
Bottelli, R
Asti, M
Bruno, S
Candusso, ME
Brambilla, S
Bono, F
Iamoni, G
Tinelli, C
Mondelli, MU
Ideo, G
机构
[1] POLICLIN SAN MATTEO,IST RICOVERO & CURA & CARATTERE SCI,DEPT INFECT DIS,I-27100 PAVIA,ITALY
[2] POLICLIN SAN MATTEO,IST RICOVERO & CURA & CARATTERE SCI,BIOSTAT UNIT,I-27100 PAVIA,ITALY
[3] UNIV PAVIA,PAVIA,ITALY
[4] OSPED NIGUARDA CA GRANDA,DIV HEPATOL CRESPI,MILAN,ITALY
[5] SAN PAOLO HOSP,DEPT MED 1,MILAN,ITALY
关键词
D O I
10.1053/gast.1996.v111.pm8698200
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Viral genotypes have been associated with different severity and outcome of hepatitis C virus (HCV)-retated liver disease. The aim of this study was to determine whether HCV genotypes may influence the cirrhosis-related risk of the development of hepatocellular carcinoma (HCC). Methods: Three groups of patients were studied: 593 patients with chronic hepatitis, 166 patients with HCC and cirrhosis, and 219 patients with cirrhosis but without HCC. A cross-sectional study of frequency distribution and a case-control analysis were performed. HCV genotypes were detected according to Okamoto. Results: HCV type 1b infection was more prevalent among patients with HCC compared with patients with cirrhosis but without HCC (P < 0.01) and chronic hepatitis (P < 0.001.). Age, male sex, and HCV type 1b significantly influenced the risk of cancer in cirrhosis by univariate analysis. A pairwise comparison performed on 162 patients with HCC and an equal number of patients with cirrhosis matched by age, sex, and Child's class showed that HCV type Ib was independently associated with HCC (odds ratio, 1.7; P = 0.026). Conclusions: HCV type 1b is overrepresented in patients with cirrhosis and HCC and significantly influences the risk of HCC in cirrhosis, independent of sex, age, and Child's class.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 50 条
  • [1] Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study
    Bruno, S
    Silini, E
    Crosignani, A
    Borzio, F
    Leandro, G
    Bono, F
    Asti, M
    Rossi, S
    Larghi, A
    Cerino, A
    Podda, M
    Mondelli, MU
    [J]. HEPATOLOGY, 1997, 25 (03) : 754 - 758
  • [2] Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol
    Tagger, A
    Donato, F
    Ribero, ML
    Chiesa, R
    Portera, G
    Gelatti, U
    Albertini, A
    Fasola, M
    Boffetta, P
    Nardi, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (05) : 695 - 699
  • [3] HEPATITIS-C VIRUS-INFECTION AS A RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CIRRHOSIS - A CASE-CONTROL STUDY
    SIMONETTI, RG
    CAMMA, C
    FIORELLO, F
    COTTONE, M
    RAPICETTA, M
    MARINO, L
    FIORENTINO, G
    CRAXI, A
    CICCAGLIONE, A
    GIUSEPPETTI, R
    STROFFOLINI, T
    PAGLIARO, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (02) : 97 - 102
  • [4] A case-control study on GB virus C hepatitis G virus infection and hepatocellular carcinoma
    Tagger, A
    Donato, F
    Ribero, ML
    Chiesa, R
    Tomasoni, V
    Portera, G
    Gelatti, U
    Albertini, A
    Fasola, M
    Nardi, G
    [J]. HEPATOLOGY, 1997, 26 (06) : 1653 - 1657
  • [5] A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China
    Zhang, JY
    Dai, M
    Wang, X
    Lu, WQ
    Li, DS
    Zhang, MX
    Wang, KJ
    Dai, LP
    Han, SG
    Zhou, YF
    Zhuang, H
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1998, 27 (04) : 574 - 578
  • [6] A case-control study on hepatitis G virus and hepatocellular carcinoma in Italy
    Tagger, A
    Donato, F
    Ribero, ML
    Chiesa, R
    Tomasoni, V
    Fasola, M
    Gelatti, U
    Albertini, A
    Portera, G
    Nardi, G
    [J]. HEPATOLOGY, 1997, 26 (04) : 1324 - 1324
  • [7] Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study
    Tomoda, Takeshi
    Nouso, Kazuhiro
    Sakai, Akiko
    Ouchida, Mamoru
    Kobayashi, Sayo
    Miyahara, Koji
    Onishi, Hideki
    Nakamura, Shinichiro
    Yamamoto, Kazuhide
    Shimizu, Kenji
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (04) : 797 - 804
  • [8] HEPATITIS C VIRUS REACTIVATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA RECEIVING RADIOTHERAPY: A CASE-CONTROL STUDY
    Angelidakis, Georgios
    Krishnan, Sunil
    Cabrera, Nicolo L.
    Jiang, Ying
    Pushparaji, Bala
    Lyos, Sebastian A.
    Kaseb, Ahmed Omar
    Torres, Harrys A.
    [J]. HEPATOLOGY, 2019, 70 : 363A - 364A
  • [9] Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study
    Dutta, U
    Byth, K
    Kench, J
    Khan, MH
    Coverdale, SA
    Weltman, M
    Lin, R
    Liddle, C
    Farrell, GC
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (03): : 300 - 307
  • [10] Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study
    Adhoute, Xavier
    Penaranda, Guillaume
    Raoul, Jean Luc
    Sellier, Floriane
    Castellani, Paul
    Oules, Valerie
    Perrier, Herve
    Lefolgoc, Gaelle
    Pol, Bernard
    Campanile, Manuela
    Bayle, Olivier
    Beaurain, Patrick
    Monnet, Olivier
    Bourliere, Marc
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (04) : 368 - 375